MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Personality Traits and Neuropsychiatric Assessment in De Novo, Clinically Established Body-First and Brain-First Parkinson’s Disease

P. Antenucci, M. Sensi, V. Resta, L. Spanedda, D. Zecchinato, G. Linzalone, A. Gozzi, L. Zerbinati (Ferrara, Italy)

Meeting: 2025 International Congress

Keywords: Non-motor Scales, Parkinson’s

Category: Parkinson's Disease: Cognition / Psychiatric Manifestations / Lewy Body Dementia

Objective: To assess and compare personality profiles and psychiatric symptoms in de-novo clinically-established body-first and brain-first PD.

Background: Body-first and brain-first have recently been proposed as new clinical-neuropathological models of PD. Evidence on neuropsychiatric symptoms and personality traits in the two remain limited.

Method: PD patients with motor symptom onset 1-2 years prior were prospectively evaluated at the Movement Disorders Clinic in Ferrara between February 1, 2023, and February 1, 2024. Demographic and clinical data (MDS-UPDRS, RBDq, NMSS, MOCA, SCOPA-AUT) were collected, along with neuropsychological and personality trait assessments (BDI-II, PAS, Diagnostic Criteria for Apathy (DCA), PDQ-39, Pathological Obsessive Compulsive Personality Scale (POPs), Big Five Inventory (BFI)).  A hybrid hierarchical k-means clustering approach among patients with RBD onset ≥1 year before motor symptoms (RBDq ≥8) and higher SCOPA-AUT and NMSS (cardiovascular/gastrointestinal) identified body-first. They were compared with a group matched for age, sex, disease duration, severity, and LEDD with no evidence of RBD, constipation or OH, representing the brain-first.

Results: Fourty-seven patients were evaluated, 10 classified as body-first and 16 as brain-first [tab1]. Eight were excluded after cluster analysis, and 13 did not meet control group criteria. Body-first showed significantly higher scores for BDI (7.5±6.2 vs 1.7±2.3, p=0.002), PAS (8.5±8.4 vs 2.4±2.4, p=0.008), POPs-Maladaptive Perfectionism (30.6±7.7 vs 27.4±7.1, p=0.040), POPs-Difficulties with Changes (23.3±8.7 vs 18.0±6.5, p=0.022), and BFI-Neuroticism (BFI-N) (22.1±6.8 vs 18.6±5.0, p=0.048), along with lower BFI-Extroversion (19.5±5.2 vs 28.0±6.1, p=0.050) [tab2]. In body-first, BDI and PAS correlated positively (0.955, 0.880) with BFI-N, a pattern not observed in the counterpart [fig1].

Conclusion: A stronger association between neuropsychiatric symptoms and body-first subtype was detected. Body-first patients are more prone to depressive symptoms (though subclinical) and struggle more with adaptation and coping in response to the diagnosis of PD. They also show higher neuroticism, maladaptive perfectionism, and resistance to change, while brain-first PD is associated with greater extroversion. In the body-first group, higher neuroticism correlates with more depressive symptoms and poorer coping.

-

–

-

–

-

–

References: Bodi, N., Keri, S., Nagy, H., Moustafa, A., Myers, C. E., Daw, N., Dibo, G., Takats, A., Bereczki, D., & Gluck, M. A. (2009). Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson’s patients. Brain, 132(9), 2385–2395. https://doi.org/10.1093/brain/awp094
Borghammer, P. (2023). The brain-first vs. body-first model of Parkinson’s disease with comparison to alternative models. Journal of Neural Transmission, 130(6), 737–753. https://doi.org/10.1007/s00702-023-02633-6
Horsager, J., Andersen, K. B., Knudsen, K., Skjærbæk, C., Fedorova, T. D., Okkels, N., Schaeffer, E., Bonkat, S. K., Geday, J., Otto, M., Sommerauer, M., Danielsen, E. H., Bech, E., Kraft, J., Munk, O. L., Hansen, S. D., Pavese, N., Göder, R., Brooks, D. J., … Borghammer, P. (2020). Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study. Brain, 143(10), 3077–3088. https://doi.org/10.1093/brain/awaa238
Horsager, J., & Borghammer, P. (2024). Brain-first vs. body-first Parkinson’s disease: An update on recent evidence. Parkinsonism & Related Disorders, 122, 106101. https://doi.org/10.1016/j.parkreldis.2024.106101
Santangelo, G., Garramone, F., Baiano, C., D’Iorio, A., Piscopo, F., Raimo, S., & Vitale, C. (2018). Personality and Parkinson’s disease: A meta-analysis. Parkinsonism & Related Disorders, 49, 67–74. https://doi.org/10.1016/j.parkreldis.2018.01.013

To cite this abstract in AMA style:

P. Antenucci, M. Sensi, V. Resta, L. Spanedda, D. Zecchinato, G. Linzalone, A. Gozzi, L. Zerbinati. Personality Traits and Neuropsychiatric Assessment in De Novo, Clinically Established Body-First and Brain-First Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/personality-traits-and-neuropsychiatric-assessment-in-de-novo-clinically-established-body-first-and-brain-first-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/personality-traits-and-neuropsychiatric-assessment-in-de-novo-clinically-established-body-first-and-brain-first-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley